Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis

Interferon beta (IFNβ) reduces disease burden in relapsing-remitting multiple sclerosis (MS) patients. In this study, IFNβ-1b-treated MS patient gene expression profiles and biological knowledgebases were integrated to study IFNβ's pleiotropic mechanisms of action. Genes involved in immune regu...

Descripción completa

Detalles Bibliográficos
Autores principales: Croze, E, Yamaguchi, K D, Knappertz, V, Reder, A T, Salamon, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793239/
https://www.ncbi.nlm.nih.gov/pubmed/22711062
http://dx.doi.org/10.1038/tpj.2012.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793239/
https://www.ncbi.nlm.nih.gov/pubmed/22711062
http://dx.doi.org/10.1038/tpj.2012.27

Ejemplares similares